Matinas BioPharma Holdings, Inc.
MTNB
$0.18
$0.00-0.87%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 65.88% | 47.17% | 57.34% | 20.19% | 14.42% |
| Total Depreciation and Amortization | -61.67% | -53.26% | -53.09% | -36.99% | -22.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.58% | -31.61% | -41.69% | 99.93% | 104.97% |
| Change in Net Operating Assets | 41.14% | -254.67% | -1,052.67% | -18.68% | -241.54% |
| Cash from Operations | 41.84% | 45.52% | 55.86% | 46.84% | 38.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -95.71% | 224.98% |
| Cash from Investing | -96.70% | -95.35% | -96.36% | -92.97% | 226.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -60.00% | -60.00% | -80.00% | 40.00% | -25.00% |
| Issuance of Common Stock | -- | -98.60% | -98.60% | -99.31% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | 0.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -1,250.00% | -- | -- | -- |
| Cash from Financing | -96.22% | -83.80% | -63.04% | -63.68% | -65.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -358.29% | -177.33% | -231.56% | -225.00% | 141.78% |